Cargando…

Endocrine significance of SARS-CoV-2’s Reliance on ACE2

Detalles Bibliográficos
Autor principal:	Chappell, Mark C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799108/ https://www.ncbi.nlm.nih.gov/pubmed/33269375 http://dx.doi.org/10.1210/endocr/bqaa222

Ejemplares similares

Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020)

SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19
por: Nesci, Salvatore
Publicado: (2021)

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
por: Monda, Vincenzo M., et al.
Publicado: (2020)

Effects of cigarette smoking on SARS‐CoV‐2 receptor ACE2 expression in the respiratory epithelium(†)
por: Heijink, Irene H, et al.
Publicado: (2021)

Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota
por: Edwinson, Adam, et al.
Publicado: (2021)

Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
por: La Vignera, Sandro, et al.
Publicado: (2020)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

Significant reduction of humoral response to SARS-CoV-2 4 months after the diagnosis of COVID-19
por: Zhang, Kang, et al.
Publicado: (2020)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

The prospects for the SARS‐CoV‐2 pandemic in Africa
por: Quaresima, Virginia, et al.
Publicado: (2020)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

SARS CoV-2 load in periodontal disease
por: Sahni, Vaibhav
Publicado: (2022)

SARS-CoV-2 persistence at subzero temperatures
por: Scarica, Catello, et al.
Publicado: (2021)

Mitigating airborne transmission of SARS-CoV-2
por: Addleman, Sarah, et al.
Publicado: (2021)

In SARS-CoV-2, astrocytes are in it for the long haul
por: Huang, Shuhan, et al.
Publicado: (2022)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV
por: Agarwal, Shubham, et al.
Publicado: (2020)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Day, Christopher J., et al.
Publicado: (2021)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020)

Therapeutic Strategies for SARS-CoV-2 acting on ACE-2
por: Vitiello, A., et al.
Publicado: (2021)

ACE2, SARS-CoV-2 und RAAS-Blocker
por: Kintscher, Ulrich, et al.
Publicado: (2021)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
por: Anand, Sai Priya, et al.
Publicado: (2020)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

Distinct Differences in the Interactions of Receptor Binding Domains of SARS-CoV-2 and SARS-CoV with Human ACE2
por: Acharya, Atanu, et al.
Publicado: (2021)

Building toward useful SARS-CoV-2 models in Africa
por: Archibong, Belinda, et al.
Publicado: (2021)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gkh21ui84eg92ct9rd2md1pcjb